These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 2895936

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of three different injectable zuclopenthixol preparations.
    Aaes-Jørgensen T.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):77-85. PubMed ID: 2568662
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacokinetics of the depot antipsychotics.
    Jann MW, Ereshefsky L, Saklad SR.
    Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
    [Abstract] [Full Text] [Related]

  • 6. Zuclopenthixol decanoate in schizophrenia: serum levels and clinical state.
    Jørgensen A, Aaes-Jørgensen T, Gravem A, Amthor KF, Dencker SJ, Rosell I, Baastrup PC, Buckhave J, Gram LF.
    Psychopharmacology (Berl); 1985; 87(3):364-7. PubMed ID: 2867572
    [Abstract] [Full Text] [Related]

  • 7. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A, Adams CE, Eisenbruch M, Quraishi S, Rathbone J.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD000307. PubMed ID: 15674872
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An open clinical trial with the long-acting neuroleptic zuclopenthixol decanoate in the maintenance treatment of schizophrenia.
    Kazi HA.
    Pharmatherapeutica; 1986 Jan 25; 4(9):555-60. PubMed ID: 3763650
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug 25; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical pharmacokinetics of haloperidol decanoate. Comparison with other prolonged-action neuroleptics].
    Levron JC, Ropert R.
    Encephale; 1987 Aug 25; 13(2):83-7. PubMed ID: 2885172
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.